CRISPR Therapeutics (CRSP) PT Lowered to $101 at Stifel
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- Discover Financial Services (DFS) Announces CEO Resignation
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- AMC Entertainment (AMC) Enters $250M ATM Agreement
Form 8-K CRISPR Therapeutics AG For: Oct 12
October 12, 2021 4:47 PM EDTExhibit 99.1
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110 in Relapsed
or Refractory CD19+ B-cell malignancies
... More